Specify a stock or a cryptocurrency in the search bar to get a summary
Nanologica AB
NICANanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide. The company operates through two segments, Drug Development and Chromatography. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA HPLC analytical columns. The company provides products for the analysis and purification of substances, with a focus on peptides and diabetes drugs. In addition, it is involved in the development of nanoporous amorphous particles (NAP), a platform technology for inhalation to give access to new or enhanced treatments for the patients with severe lung diseases. Nanologica AB (publ) was incorporated in 2004 and is headquartered in Södertälje, Sweden. Address: Forskargatan 20 G, Södertälje, Sweden, 151 36
Analytics
WallStreet Target Price
111.84 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures NICA
Dividend Analytics NICA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NICA
Stock Valuation NICA
Financials NICA
Results | 2019 | Dynamics |